obtaining written informed consents from the patients undergoing assisted reproductive technology treatment, came from various clinical useless embryos, including: poor quality embryos, abnormal embryos after pre-implantation genetic diagnosis (PGD), zygotes with abnormal pronuclear number and partheno-activated embryos. These embryos were cultured to blastocyst stage in G-series sequential medium (Vitrolife, Gothenburg, Sweden). Then, each blasotocyst was mechanically cut in half, and the half containing inner cell mass (ICM) was plated onto a feeder layer of mitotically inactivated human embryonic fibroblasts (HEFs) at a density of approximately 5,000 cells/cm 2 , which were derived from an 2-month-age aborted fetus and cultured in our laboratory as previously described [1] . For the initial several passages, cells were cultured in DFSR medium containing DMEM/F12 supplemented with 15% knockout serum replacement, 2mM nonessential amino acids, 2mM L-glutamine, 0.1mM β-mercaptoethanol and 50ng/ml of basic Fibroblast Growth Factor (bFGF) (all from Invitrogen; Carlsbad, CA, USA).
The medium was changed every other day and hESCs were mechanically passaged every 7 days.
Once established and propagated for several passages, hESCs were transferred to DFSR medium containing 4 ng/ml bFGF for long-term propagation. All 188 hESC lines were cryopreserved by the open-pulled-straw vitrification method.
In vitro and in vivo differentiation
For in vitro differentiation assay, hESC colonies cultured on HEF feeders were mechanically dissociated into small clumps and detached to grow as aggregates in suspension for 7 days to form embryoid bodies in DFSR medium without bFGF. The embryoid bodies were then transferred to gelatin-coated six-well plate for adherent culture for 2 weeks in the same medium, followed by immunocytochemistry analysis.
For in vivo differentiation assay, 2~3×10 6 hESCs were injected intramuscularly into the rear leg of 6-8-week-old mice with severe combined immunodeficiency disease (SCID). The mice were sacrificed 8~10 weeks post-injection and the xenografts were removed and processed for histological analysis by haematoxylin and eosin (H&E) staining.
Immunohistochemistry and alkaline phosphatase staining
Undifferentiated and spontaneously differentiated Cells were fixed in 4% paraformaldehyde at room temperature for 20 minutes, then blocked with 4% goat serum in PBS and incubated with primary antibodies diluted in blocking solution overnight at 4°C. For intracellular antigen, cells were permeabilized for 10 minutes in 0.1% Triton-X 100 before blocking. The following primary antibodies were used: mouse anti-Tra-1-60, mouse anti-Tra-1-81 (Chemicon; Temecula, CA, USA; 1:50), mouse anti-SSEA4 (R & D Systems; Minneapolis, USA; 1:100), rat anti-SSEA3, mouse anti-Oct-3/4 (Santa Cruz Biotechnology; Santa Cruz, USA; 1:50) for characterization of undifferentiated molecular markers of hESCs; mouse anti-β-tubulin (sigma; St Louis, MO, USA, 1:800),, mouse anti-AFP (sigma; St Louis, MO, USA, 1:1000), mouse anti-SMA (Chemicon;
1:100) for in vitro differentiation assay. Unbound antibody was removed by extensive washing, and Localization of antigens was visualized by using Alexa Fluor 488 secondary antibody (Invitrogen; 1:1000). Nuclei were counterstained with DAPI (Sigma; 1:1000).
Alkaline phosphatase activity was detected with the Fast Red Substrate Pack (Zymed Laboratories, South San Francisco, USA) according to the manufacturer's recommendations.
Karyotype analysis
hESCs were transferred to matrigel (BD; Franklin Lakes, NJ, USA) coated dishes for further propagation and prevention of HEF contamination. After being fed with HEF-conditioned media for 3 days, the cells were treated with 80ng/ml colcemid (Invitrogen) for 3.5h and dissociated with 0.05% Trypsin/ EDTA (Invitrogen) into singe cells for standard G-banding karyotype analysis. Usually above 5-10 metaphases were analyzed for every sample.
RT-PCR analysis of pluripotency related genes and Telomerase activity
Total RNA was isolated with TRIzol (Invitrogen) and cDNA was synthesized using 1 μg of total RNA in a 20ul reaction by RevertAid TM first strand cDNA synthesis kit (Fermentas Life Sciences; 58   TDGF1  139  5'-TCCTTCTACGGACGGAACTG-3'  56   5'-AGAAATGCCTGAGGAAAGCA-3'  THY1  273  5'-AGAATACCAGCAGTTCACCCATCC-3'  5'-CCTCACACTTGACCAGTTTGTCTCTG-3'   58   LEFTB  222  5'-AGAGGGTGCTAAGAGGAAGGATGA-3'  5'-GAGTGGGCAGGGGTAGGTAGG-3'   58   DPPA2  372  5'-TACCCACATCCTCTCCGTC-3'  5'-CTTCCCTTGCCGACCATT-3'   58   FGF4  230  5'-GCGTGGTGAGCATCTTCG-3'  5'-GGTGACCTTCATGGTGGG-3'   54 The telomerase activity of the hESCs was measured using a TRAPeze Telomerase detection kit (Chemicon) according to the manufacturer's instructions.
DNA fingerprinting analysis
For DNA fingerprinting analysis, hESCs were transferred to matrigel-plated dishes for further expansion as well as excluding the contamination of HEFs. 
Genome-wide SNP analysis of HLA homozygous hESC lines
Total genomic DNA was extracted from the HLA homozygous hESCs by DNeasy Tissue kit (Qiagen) and the SNP analysis was performed with Genome-Wide Human SNP Array 5.0 (Affymetrix, Santa Clara, USA). A previously described method [2] was used to analyze the data and calculate the homozygosity throughout the genome of each cell line. Briefly, we divided each chromosome into the block of 1Mb from the centromere and then calculated the heterozygous SNP frequency in each block. We assigned homozygosity to any block where the heterozygous SNP frequency was at or below 5.0%. Genotyping data for the hemizygous X chromosome from the male hESC line chHES-152 served as a control of genotyping error rates.
Across the single X chromosome, 0.5% of genotypes were reported as heterozygous.
HLA genotyping and matching analysis
DNA typing of human leukocyte antigen (HLA)-A, -B and -DR loci was carried out on all the 188 hESC lines. The hESCs were transferred to gelatin-plated dishes for further culture to exclude the contamination of HEFs. Total genomic DNA was extracted from undifferentiated hESCs by DNeasy Blood & Tissue kit (Qiagen) according to the protocol. The HLA types were performed using AB/DR SSP UniTray (Invitrogen, Brown Deer, WI, USA) and HISTO TYPE DRAB (BAG Health Care, Lich, Germany) by a polymerase chain reaction-sequence-specific primers (PCR-SSP) method [3] . DNA typing of blood group ABO was conducted also based on PCR-SSP technique by ABO SSPTyper Genotyping System (G&T Biotech, Rockville, MD, USA). 174 cell lines with diploidic genotypes were further used for HLA matching estimation.
We assumed that the whole Hunan population could be beneficial from the hESC bank and took out 5236 unrelated individuals (2877 male and 2359 female) from Hunan Province Branch of Chinese Marrow Donor Program (CMDP) as assumed patients who need organ transplantation or other stem cell therapy. These donors come from 14 regions of Hunan and consist of 6 ethnic groups such as Han (98.01%), Tujia (0.71%), Miao (0.52%), Bai (0.11%), Dong (0.38%) and Yao (0.25%). The latter 5 minorities are the most common ones in Hunan Province.
The allele frequency analysis was conducted with PyPop software and the haplotype frequency was calculated using the Expectation-Maximization (EM) algorithm with Arlequin 3.1 software [4] [5] . The significant differences of HLA allele frequencies between the 174 hESC lines and the assumed patients were confirmed by chi-square test. The accumulated proportions were calculated of the 5236 patients who can find at least one HLA-matched donor among the 174 hESC lines with 6 different levels of HLA matching: full match (0-0-0), a single mismatch at HLA-A locus or better (1-0-0), a single mismatch at HLA-B locus or better (0-1-0), a single mismatch at HLA-DR locus or better (0-0-1), single mismatches at two loci of HLA-A and HLA-B or better (1-1-0), zero HLA-DR mismatch or better (*-*-0).
Statistical analysis
The statistical significance (P values) in derivation efficiency of different grades embryos as well as between normal and abnormal embryos was determined with a chi-square test. The level of significance was set to P<0.05. Statistical analyses were carried out with the SPSS13.0 software.
Request stem cell lines
All the hESC lines ready for distribution in our bank are available and free of charge for academic purpose, but the shipping fee is required. To request stem cell line, please visit our hESC bank website (http://www.hescbank.cn).
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